HealthEquity Aktie
82,50
EUR
-0,50
EUR
-0,60
%
95,39
USD
+3,11
USD
+3,37
%
HealthEquity jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
HealthEquity Aktie Analyse
| 07.02.19 | HealthEquity Buy | Chardan Capital Markets | |
| 20.03.18 | HealthEquity Buy | Chardan Capital Markets | |
| 06.12.17 | HealthEquity Buy | Chardan Capital Markets | |
| 07.06.17 | HealthEquity Buy | Chardan Capital Markets | |
| 31.03.17 | HealthEquity Overweight | Cantor Fitzgerald | |
| 22.03.17 | HealthEquity Buy | Chardan Capital Markets | |
| 13.12.16 | HealthEquity Buy | Chardan Capital Markets | |
| 08.09.16 | HealthEquity Outperform | Barrington Research | |
|
Werbung
|
|||
| 08.12.15 | HealthEquity Outperform | Barrington Research | |
Werbung
Werbung